Varaico: Literature-Extracted Genetic Variants

Gene:CYB5A
Variant:p.S5A
Back to variants list

CYB5A

NM_148923.4:p.S5A

Associated Papers

Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition.

Fiorica PN et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2025

39992227 (PubMed )
Supplement: ccr-24-2785_supplementary_data_1_suppds1.xlsx › Supplemental_Table_3

Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.

Sprissler R et al.

Cancers, 2020

32570879 (PubMed )
Supplement: cancers-12-01618-s001.zip › cancers-817200-Supplementary_Materials3 › Supplementary_table_S1.xlsx › TSG

Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women.

Blanke KL et al.

Cancer Causes & Control : Ccc, 2014

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.

Sacco JC et al.

Pharmacogenetics and Genomics, 2012

Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.

Rhoads K et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology, 2011

Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.

Sacco JC et al.

Pharmacogenetics and Genomics, 2010

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."